SECsense Logo

Arcus Biosciences, Inc. 8-K Current Report: Key Insights from February 18, 2025

$RCUS
Form 8-K
Filed on: 2025-02-19
Source
Arcus Biosciences, Inc. 8-K Current Report: Key Insights from February 18, 2025

Here are the key pieces of information extracted from the provided section of the financial report:

  1. Entity Information:
  • Company Name: Arcus Biosciences, Inc.
  • CIK: 0001724521
  • Industry: Biopharmaceuticals (inferred from company name)
  • Location: 3928 Point Eden Way, Hayward, CA 94545
  • Contact Number: (510) 694-6200
  • Stock Exchange: NYSE
  • Ticker Symbol: RCUS
  1. Filing Information:
  • Filing Type: 8-K (Current Report)
  • Filing Date: February 18, 2025
  1. Financial Data:
  • Common Stock Par Value: $0.0001 per share
  1. Contextual Information:
  • Report Period: The report covers a single day, February 18, 2025.
  1. Entity Identifier:
  • IRS Employer Identification Number (EIN): 47-3898435

Insights:

  • The filing is a current report (8-K), typically used to disclose major events that shareholders should know about. The specific details of the event are not provided in the snippet.
  • The company operates in the biotechnology sector, which may indicate potential growth opportunities, especially if there are new product launches, clinical trial results, or partnerships disclosed in the full report.
  • The report is specific to a single day, suggesting it may relate to a particular event or announcement rather than ongoing financial performance.
  • The par value of the stock is quite low, which is common in biotech firms that may have high volatility and varying valuations based on developmental milestones.

This summary captures the essential elements relevant for financial analysis and investor consideration. Further investigation would require additional context or details about the content of the 8-K filing.